Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ERCC1-XPF-IN-2 在核苷酸切除修复、顺铂增强和 γH2AX 测定中具有活性。ERCC1-XPF-IN-2 是 ERCC1-XPF 核酸内切酶的有效抑制剂,IC50值为 0.6 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 287 | 现货 | ||
5 mg | ¥ 463 | 现货 | ||
10 mg | ¥ 791 | 现货 | ||
25 mg | ¥ 1,590 | 现货 | ||
50 mg | ¥ 2,550 | 现货 | ||
100 mg | ¥ 3,810 | 现货 | ||
200 mg | ¥ 5,110 | 现货 | ||
500 mg | ¥ 7,980 | 现货 |
产品描述 | ERCC1-XPF-IN-2 is active in nucleotide excision repair, cisplatin enhancement and γH2AX assays. ERCC1-XPF-IN-2 is a potent inhibitor of ERCC1-XPF endonuclease with an IC 50 value of 0.6 μM [1]. |
体外活性 | ERCC1-XPF-IN-2 (compound 13) (0-100 µM) shows DNase I and FEN-1 activity with IC50s of >100, >100 µM, respectively. ERCC1-XPF-IN-2 shows binding kinetics with Kd of ~30 µM. ERCC1-XPF-IN-2 has nontoxic to Hep-G2 cells at 10 µM and relatively short mouse and human microsomal half-lives with t1/2 of 23 min and 28 min for mouse and human, respectively. ERCC1-XPF-IN-2 (0-60 µM; 24 h) shows inhibition of nucleotide excision repair (NER) with an IC50 of 15.6 μM in A375 cells. ERCC1-XPF-IN-2 (0-60 µM) increases the cisplatin activity with nontoxic. ERCC1-XPF-IN-2 (10 µM; 6h) causes a delay in DNA repair by a right shift towards higher numbers of γH2AX foci per cell[1]. |
分子量 | 326.17 |
分子式 | C15H13Cl2NO3 |
CAS No. | 1808986-37-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225.0 mg/mL (689.8 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0659 mL | 15.3294 mL | 30.6589 mL | 76.6471 mL |
5 mM | 0.6132 mL | 3.0659 mL | 6.1318 mL | 15.3294 mL | |
10 mM | 0.3066 mL | 1.5329 mL | 3.0659 mL | 7.6647 mL | |
20 mM | 0.1533 mL | 0.7665 mL | 1.5329 mL | 3.8324 mL | |
50 mM | 0.0613 mL | 0.3066 mL | 0.6132 mL | 1.5329 mL | |
100 mM | 0.0307 mL | 0.1533 mL | 0.3066 mL | 0.7665 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
ERCC1-XPF-IN-2 1808986-37-9 Others Inhibitor inhibitor inhibit